Active Ratio Test (ART) as a Novel Diagnostic for Ovarian Cancer.

Kang, Sung-Woog; Rainczuk, Adam; Oehler, Martin K; Jobling, Thomas W; Plebanski, Magdalena; Stephens, Andrew N

Kang, Sung-Woog; Rainczuk, Adam; Oehler, Martin K; Jobling, Thomas W; Plebanski, Magdalena; Stephens, Andrew N.

Affiliation

Kang SW; Hudson Institute of Medical Research, Clayton 3168, Australia.
Rainczuk A; Department of Molecular and Translational Sciences, Monash University, Clayton 3168, Australia.
Oehler MK; Hudson Institute of Medical Research, Clayton 3168, Australia.
Jobling TW; Department of Molecular and Translational Sciences, Monash University, Clayton 3168, Australia.
Plebanski M; Bruker Pty Ltd., Preston 3072, Australia.
Stephens AN; Department of Gynaecological Oncology, Royal Adelaide Hospital, Adelaide 5000, Australia.

Diagnostics (Basel) ; 11(6)2021 Jun 07.

Article de En | MEDLINE | ID: mdl-34200333

Mots clés

Active Ratio Test; CXCL10; ELISA; biomarkers; early detection; ovarian cancer

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Type d'étude: Diagnostic_studies / Screening_studies Langue: En Journal: Diagnostics (Basel) Année: 2021 Type de document: Article Pays d'affiliation: Australie Pays de publication: Suisse

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google